Document ID: chunk:federal_register_of_legislation:F2020L01084:reg:9
Version: federal_register_of_legislation:F2020L01084
Segment Type: reg
Provision Reference: reg 9
Character Range: 3819–5963

9               Factors that must exist
At least one of the following factors must exist before it can be said that, on the balance of probabilities, pure red cell aplasia or death from pure red cell aplasia is connected with the circumstances of a person's relevant service:
(1)          being pregnant at the time of the clinical onset of pure red cell aplasia;
(2)          being treated with a drug specified in the Schedule 2 - Drugs of this Instrument within the six months before the clinical onset of pure red cell aplasia;
(3)          being treated with a drug which is associated in the individual with:
(a)          the development of pure red cell aplasia within six months of drug therapy; and
(b)          the improvement of pure red cell aplasia within six months of discontinuing or tapering drug therapy;
(4)          being exposed to benzene as specified on at least 45 days within the six months before the clinical onset of pure red cell aplasia;
Note: being exposed to benzene as specified is defined in the Schedule 1 - Dictionary.
(5)          having acute hepatitis within the one year before the clinical onset of pure red cell aplasia;
(6)          having a liver transplant within the three months before the clinical onset of pure red cell aplasia;
(7)          having an autoimmune disease from the specified list of autoimmune diseases within the two years before the clinical onset of pure red cell aplasia;
Note: specified list of autoimmune diseases is defined in the Schedule 1 - Dictionary.
(8)           having               chronic lymphocytic leukaemia/small lymphocytic lymphoma or T-cell large granular lymphocytic leukaemia within the six months before the clinical onset of pure red cell aplasia;
(9)          having a thymoma or thymic carcinoma before the clinical onset of pure red cell aplasia;
(10)      having an infection with parvovirus B19 within the six months before the clinical onset of pure red cell aplasia;
(11)      being pregnant at the time of the clinical worsening of pure red cell aplasia;
(12)      inability to obtain appropriate clinical management for pure red cell aplasia.